SMARCA4 and childhood malignant neoplasm: Somatic mutations in SMARCA4 are associated with childhood cancers (Howe et al., 2006; Turnbull et al., 2012; Fu et al., 2017; Jia et al., 2017), including Wilms tumors (4.5% prevalence) (Rakheja et al., 2014).